Effect of low-molecular weight trypsin inhibitor, nafamostat mesilate, on trypsin activity using the pancreatic acinar cells.
Hashimoto
Daisuke
D
Ohmuraya
Masaki
M
Wang
Jun
J
Yamamura
Ken-ichi
K
Hirota
Masahiko
M
Baba
Hideo
H
D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D001550:Benzamidines; D002478:Cells, Cultured; D004789:Enzyme Activation / Q000187:drug effects; D006023:Glycoproteins / Q000172:deficiency / Q000235:genetics; D006146:Guanidines / Q000737:chemistry / Q000494:pharmacology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008970:Molecular Weight; D010179:Pancreas / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D029584:Prostatic Secretory Proteins / Q000235:genetics; D014357:Trypsin / Q000378:metabolism*; D014359:Trypsin Inhibitor, Kazal Pancreatic; D014361:Trypsin Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D014362:Trypsinogen / Q000378:metabolism
D001550:Benzamidines; D006023:Glycoproteins; D006146:Guanidines; D029584:Prostatic Secretory Proteins; C487134:Spink1 protein, mouse; D014361:Trypsin Inhibitors; D014359:Trypsin Inhibitor, Kazal Pancreatic; D014362:Trypsinogen; D007611:Aprotinin; D014357:Trypsin; C032855:nafamostat